Why is the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market advancing cardiac care outcomes?
Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Intelligence: Size, Segmentation & Clinical Outlook 2026–2035 📥 Download Sample Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size, Competitive Landscape & Forecast 2026–2035 Global coronary interventions annually: 12+ million procedures Cardiovascular disease share of global deaths: 32% Restenosis reduction with DEB therapy: up to 40% 1.0 Strategic Snapshot of the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Over 20 million cardiovascular-related deaths are recorded annually, driving interventional demand. Drug eluting balloons are used in nearly 18% of restenosis-focused angioplasty procedures worldwide. More than 65% of advanced cardiac centers in developed regions have integrated DEB therapy. Target lesion revascularization rates drop by approximately 35% with optimized drug-...